J, H., L, V., M, v. S., I, N., M, d. M., J, v. d. B., . . . HM, H. (2020). Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials. NPJ breast cancer, 6, 15. https://doi.org/10.1038/s41523-020-0155-1
Chicago Style (17th ed.) CitationJ, Hudeček, et al. "Application of a Risk-management Framework for Integration of Stromal Tumor-infiltrating Lymphocytes in Clinical Trials." NPJ Breast Cancer 6 (2020): 15. https://doi.org/10.1038/s41523-020-0155-1.
MLA (9th ed.) CitationJ, Hudeček, et al. "Application of a Risk-management Framework for Integration of Stromal Tumor-infiltrating Lymphocytes in Clinical Trials." NPJ Breast Cancer, vol. 6, 2020, p. 15, https://doi.org/10.1038/s41523-020-0155-1.
Warning: These citations may not always be 100% accurate.
